R Herbst
Overview
Explore the profile of R Herbst including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
1128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meyer M, Peters S, Mok T, Lam S, Yang P, Aggarwal C, et al.
Ann Oncol
. 2024 Oct;
35(12):1088-1104.
PMID: 39413875
Background: Lung cancer remains a critical public health issue, presenting multifaceted challenges in prevention, diagnosis, and treatment. This article aims to review the current landscape of lung cancer research and...
2.
3.
Passaro A, Leighl N, Blackhall F, Popat S, Kerr K, Ahn M, et al.
Ann Oncol
. 2022 Feb;
33(5):466-487.
PMID: 35176458
The European Society for Medical Oncology (ESMO) held a virtual consensus-building process on epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer in 2021. The consensus included a multidisciplinary panel of...
4.
Gutzmer R, Schulze H, Hauschild A, Leiter U, Meier F, Haferkamp S, et al.
J Eur Acad Dermatol Venereol
. 2021 May;
35(8):1678-1685.
PMID: 33931910
Background: Basal cell carcinoma (BCC) can arise by the uncontrolled proliferation of cells from multiple epidermal compartments due to aberrant activation of the Hedgehog (Hh) signalling pathway. Vismodegib, a small-molecule...
5.
Boulle G, Velut Y, Mansuet-Lupo A, Gibault L, Blons H, Fournel L, et al.
Eur J Cancer
. 2020 Jul;
135:221-229.
PMID: 32610210
Background: Radiotherapy is a standard of care for locally advanced stage III N2 non-small-cell lung carcinoma (NSCLC) combined with surgery/chemotherapy. Radiotherapy is hypothesised to induce tumour immunogenic cell death, to...
6.
Livingstone E, Zaremba A, Horn S, Ugurel S, Casalini B, Schlaak M, et al.
Br J Dermatol
. 2020 Feb;
183(5):928-939.
PMID: 32064597
Background: GNAQ and GNA11 mutant nonuveal melanoma represent a poorly characterized rare subgroup of melanoma with a gene mutation profile similar to uveal melanoma. Objectives: To characterize these tumours in...
7.
Ugurel S, Schadendorf D, Horny K, Sucker A, Schramm S, Utikal J, et al.
Ann Oncol
. 2020 Jan;
31(1):144-152.
PMID: 31912789
Background: Programmed cell death protein 1 (PD-1) checkpoint inhibition has recently advanced to one of the most effective treatment strategies in melanoma. Nevertheless, a considerable proportion of patients show upfront...
8.
Rosch N, Schnadt S, Herbst R, Arens-Volland A, Kohler S, Feidert F, et al.
Allergol Select
. 2019 Dec;
2(1):17-28.
PMID: 31826030
Introduction: Patients affected by food allergies and intolerance need to apply dedicated avoidance strategies and also prevent the consequences of unbalanced diets. In most countries, the health economic costs for...
9.
Corrie P, Terheyden P, Ten Tije A, Herbst R, Jansen R, Marples M, et al.
Br J Dermatol
. 2018 Nov;
180(5):1254-1255.
PMID: 30488430
No abstract available.
10.
Groves C, Carrell J, Grady R, Rajan B, Morehouse C, Halpin R, et al.
Blood Adv
. 2018 Nov;
2(22):3163-3176.
PMID: 30478153
Long-lived antibody-secreting cells (ASCs) are critical for the maintenance of humoral immunity through the continued production of antibodies specific for previously encountered pathogen or vaccine antigens. Recent reports describing humoral...